Namrata Kumar
Physician Assistant · Elyria, OHNPI 1407910896
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 39 manufacturers reported payments, led by Zealand Pharma US, Inc. at 44.1% of the total. Reporting peaked in 2021 at $12,410 and has fallen 80.1% since, to $2,470 in 2025. Among physician assistant clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 512 payments — averaging $43.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zealand Pharma US, Inc.$10K
- Mannkind Corporation$3K
- Novo Nordisk$1K
- Xeris Pharmaceuticals, Inc.$1K
- Corcept Therapeutics$982
- Dexcom, Inc.$654
- plus $5K from 33 others
What the payments were for
- Consulting fees$7,69534%
- Travel & lodging$2,0349%
- Food & beverage$12,70756%
- Education$750%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zealand Pharma US, Inc. | 17 | $9,928 |
| Mannkind Corporation | 91 | $2,602 |
| Novo Nordisk | 73 | $1,497 |
| Xeris Pharmaceuticals, Inc. | 47 | $1,423 |
| Corcept Therapeutics | 46 | $982 |
| Dexcom, Inc. | 31 | $654 |
| Lilly USA, LLC | 35 | $639 |
| Amgen(2 entities) | 16 | $577 |
| Sanofi-aventis U.S. LLC | 13 | $526 |
| Ascendis Pharma Endocrinology Inc | 14 | $396 |
| Bayer | 12 | $339 |
| Abbott | 20 | $328 |
| Merck | 15 | $310 |
| Medtronic | 4 | $294 |
| Ascensia Diabetes Care US Inc. | 6 | $261 |
| Inspire Medical Systems, Inc. | 4 | $246 |
| Recordati_rare_diseases_inc. | 10 | $236 |
| AstraZeneca | 11 | $188 |
| Madrigal Pharmaceuticals | 5 | $131 |
| Boehringer Ingelheim | 5 | $118 |
| BETA Bionics, Inc. | 1 | $109 |
| IBSA Pharma Inc. | 5 | $97 |
| Amneal Pharmaceuticals LLC | 4 | $96 |
| Amarin Pharma, Inc. | 4 | $75 |
| Lifescan, Inc. | 4 | $64 |
| Amryt Pharma Holdings Ltd | 2 | $49 |
| Acella Pharmaceuticals, LLC | 2 | $41 |
| Kyowa Kirin, Inc. | 2 | $40 |
| Insulet Corporation | 2 | $34 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $31 |
| Cequr Corporation | 1 | $31 |
| BD | 1 | $26 |
| Halozyme Inc | 1 | $24 |
| Neurocrine Biosciences, Inc. | 1 | $24 |
| AbbVie | 1 | $21 |
| Clarus Therapeutics Inc. | 1 | $21 |
| GSK | 1 | $19 |
| Endo Pharmaceuticals Inc. | 1 | $18 |
| Antares Pharma, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- V-GO DISPOSABLE INSULIN DELIVERY$9,838
- AFREZZA$601
- iLet Bionic Pancreas$326
- TEPEZZA$249
- GVOKE PFS$230
- GVOKE HYPOPEN$224
- MINIMED 780G$129
- TZIELD$128
- EVERSENSE E3 SENSOR KIT - RETAIL$123
- DEXCOM G6 TRANSMITTER$121
- Inspire$114
- SOLIQUA 100/33$107
- ClosureFast$105
- Yorvipath$102
How this compares
$22,511 in reported general payments places this provider in the 95th percentile of 4,098 physician assistant providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 103 | $150,405 |
| TrulicityDulaglutide | 69 | $82,598 |
| JanuviaSitagliptin Phosphate | 29 | $25,553 |
| RybelsusSemaglutide | 13 | $23,547 |
| Tresiba Flextouch U-200Insulin Degludec | 25 | $23,283 |
| FarxigaDapagliflozin Propanediol | 18 | $22,139 |
| JardianceEmpagliflozin | 23 | $21,520 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 140 | $21,126 |
| Gvoke Hypopen 2-PackGlucagon | 24 | $14,659 |
| Humalog Kwikpen U-100Insulin Lispro | 43 | $14,199 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 29 | $6,774 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 20 | $6,347 |
| Novolog FlexpenInsulin Aspart | 22 | $5,172 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 33 | $4,070 |
| HumalogInsulin Lispro | 11 | $3,059 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $1,497 | $173,951116 claims |
| Lilly USA, LLCTrulicity, Humalog | $639 | $85,65880 claims |
| MerckJanuvia | $310 | $25,55329 claims |
| AstraZenecaFarxiga | $188 | $22,13918 claims |
| Boehringer IngelheimJardiance | $118 | $21,52023 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $96 | $2,933320 claims |
| AbbVieSynthroid | $21 | $44323 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,098 physician assistant providers in Ohio.
Other physician assistant in Elyria
- Steven WurzelbacherCincinnati$309K
- Emily AnkromDayton$192K
- Amanda MaggartWorthington$164K
- Megan SevillaMayfield Heights$132K
- Erin StrculaBelpre$106K
- Sarah LaubNew Albany$100K
- Jessica RhominskiCanal Winchester$78K
- Brook GramBeloit$52K
- Alison FleigToledo$48K
- Alicia PerkinsColumbus$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.